Posted by Michael Wonder on 17 Oct 2016
Valeant sets price increases for some drugs
14 October 2016 - CEO says increases ‘demonstrate that we are taking our approach to responsible pricing seriously’.
Valeant Pharmaceuticals on Friday said it was raising the prices of its stomach, neurology and urology drugs from 2% to 9%, effective immediately.
The company also said it wouldn’t increase the prices of its eye and skin drugs at all this year. Yet Wells Fargo Securities said Valeant raised the price of three eye drugs in September, each by 9.9%.
The Canadian company’s practice of buying drugs and raising the prices of drugs like heart treatments Nitropress and Isuprel by sizable percentages has drawn scrutiny from doctors, hospitals and members of Congress.
